ResMed Analysts Recommendations and Consensus

RMD -- USA Stock  

USD 100.93  4.10  3.90%

The prevalent analyst and expert consensus on ResMed is Hold with 3 strong sell openions. The current projected target price consensus is 63.18 with 9 total expert opinions. On of the most common way ResMed analysists use to generate public recommendation is conference and earning calls analysis. In addition, many experts are talking to ResMed vendors, executives, and/or customers to validate their buy or sell advice.ResMed recommendation module provides average expert sentiment on the projected ResMed target price to derive its highest and lowest estimates based on target estimated volatility of 8.499. Additionally take a look at Macroaxis Advice on ResMed to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

ResMed Target Price Consensus

Number of Opinions11
Lowered Outlook0
Raized Outlook0
Hold
Macroaxis Recommendation   Exposure   Valuation

ResMed Target Price Projection

Current Price

ResMed Market Quote

Low Price105.03Odds
High Price100.93Odds

100.93

Target Price

Analyst Consensus On Target Price

Low Estimate50.0Odds
High Estimate73.1Odds
Number of Analysts9
Standard Deviation8.499

63.177

ResMed Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Real Estate
Purchased over 100 shares
Traded few hours ago for 41.84
Energy
Purchased over 100 shares
Traded few hours ago for 28.79
Artificial Intelligence
Purchased over 100 shares
Traded few hours ago for 108.66
Energy
Purchased over 100 shares
Traded few hours ago for 23.66
Real Estate
Purchased over 100 shares
Traded few hours ago for 39.68
Artificial Intelligence
Purchased over 100 shares
Traded few hours ago for 72.29
Additionally take a look at Macroaxis Advice on ResMed to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com